A share price of Fresenius Medical Care AG ADR [FMS] is currently trading at $25.57, up 0.91%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The FMS shares have gain 2.86% over the last week, with a monthly amount glided 2.94%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Fresenius Medical Care AG ADR [NYSE: FMS] stock has seen the most recent analyst activity on September 02, 2025, when UBS downgraded its rating to a Sell. Previously, BofA Securities upgraded its rating to Neutral on December 02, 2024. On November 06, 2024, Berenberg initiated with a Buy rating and assigned a price target of $25.60 on the stock. Morgan Stanley downgraded its rating to a Underweight. HSBC Securities upgraded its rating to a Hold. Societe Generale upgraded its rating to Buy for this stock on November 17, 2023. In a note dated August 14, 2023, UBS downgraded an Neutral rating on this stock.
Fresenius Medical Care AG ADR experienced fluctuations in its stock price throughout the past year between $18.94 and $30.46. Currently, Wall Street analysts expect the stock to reach $17.85 within the next 12 months. Fresenius Medical Care AG ADR [NYSE: FMS] shares were valued at $25.57 at the most recent close of the market. An investor can expect a potential drop of -30.19% based on the average FMS price forecast.
Analyzing the FMS fundamentals
Trailing Twelve Months sales for Fresenius Medical Care AG ADR [NYSE:FMS] were 21.23B which represents 5.93% growth. Gross Profit Margin for this corporation currently stands at 0.25% with Operating Profit Margin at 0.08%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.03%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.05 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.83.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Fresenius Medical Care AG ADR [NYSE:FMS] is 1.44. In addition, the Quick Ratio stands at 1.08 and the Cash Ratio stands at 0.3. Considering the valuation of this stock, the price to sales ratio is 0.70, the price to book ratio is 0.96 and price to earnings (TTM) ratio is 20.84.
